The crux of the problem is change, specifically the Rs 500 note, which India's presses cannot, currently, print in adequate number, says Sahil Kini/IndiaSpend.
Modi can waive loans of the country's rich but can't do the same for farmers, he said.
Many countries advised the return the high-denomination notes to the central bank for destruction, but these continued to be legal tender. This and the introduction of a new Rs 2,000 note in India are the two major differences between Indian demonetisation and those of other countries.
Opposition parties in Parliament on Monday vociferously protested the "snooping" on Rahul Gandhi, with the government dismissing their contention saying they were making a "mountain out of what is not even a molehill", leading the Congress to walk out of Rajya Sabha.
James Wilson explains why Indians are destined to silently suffer the cash shortage for half a dozen more months.
The minister tells Subhomoy Bhattacharjee that he wants to set up a financing corporation for the road and shipping sectors, which will throw up a business opportunity of Rs 25 lakh crore!
DCGI, health ministry initiate dialogues with foreign regulators, try to understand global best practices
Ranbaxy Laboratories on Thursday said it will co-operate fully with any regulator from anywhere in the world wanting to investigate its manufacturing practices.
As the dust finally settles on the outcome of the Lok Sabha elections 2019 and Bharatiya Janata Party along with its NDA allies emerges as the clear winner, here is a list of who won in each of the 7 phases of elections.
'If the BJP thinks they can suppress the farmers' movement by opening fire, they are wrong.' 'It will create a boomerang effect which will be very difficult to manage.'
Details on prices sought as 10 generic drugs become up to 83 times costlier in 6 months
And when an inspector asked about the contents of unlabelled vials in the laboratory glassware washing area, a plant worker dumped them down a sink and said the contents could not be determined, according to a July 18 letter from the US Food and Drug Administration to Wockhardt, which makes sterile injectable drugs and various forms of insulin.